Chronic Respiratory Diseases
8
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Belgian Lung Function Study
Chinese Population Health and Multimorbidity Study
Interest of Cryotherapy in Reducing Pain During Radial Arterial Blood Sampling
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
Intestinal Microbiota in COPD and Asthma
Evaluating the Relationship Between Environmental Risk Factors in Housing Types and Chronic Respiratory Diseases in Ho Chi Minh City
Phenotyping the Chronic Respiratory Diseases (CRD) in Ho Chi Minh City, Vietnam